The association between diplopia and clinical phenotypes in spinocerebellar ataxia type 3. [PDF]
Zheng M +5 more
europepmc +1 more source
IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]
Chiu C +8 more
europepmc +1 more source
Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. [PDF]
Potashman M +14 more
europepmc +1 more source
Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3. [PDF]
Petit E +29 more
europepmc +1 more source
Physiotherapy in Spinocerebellar Ataxia Following COVID-19: A Biomechanical and Biopsychosocial Case Report. [PDF]
Monteiro LHF +5 more
europepmc +1 more source
Spinocerebellar ataxia with mixed tremor and hippocampal atrophy: case report and literature review. [PDF]
Wang X, Zhou B, Guo Z, Shao W.
europepmc +1 more source
Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1. [PDF]
Lee C +9 more
europepmc +1 more source
Clinical Characteristics of Patients with Spinocerebellar Ataxia 7
Spinocerebellar ataxia type 7 (SCA7) is a rare autosomal dominantly inherited neurodegenerative disorder. It is due to abnormal CAG trinucleotide repeat expansion. SCA7 is the only inherited ataxia invariably associated with a cone-rod dystrophy.
Randee Miller; Gregory Van Stavern
core
An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar Ataxia. [PDF]
Brown BN +13 more
europepmc +1 more source

